Neuropace Inc (NPCE) — Capital Reinvestment Ratio

Latest as of December 2025: 0.19x

Neuropace Inc (NPCE) has a Capital Reinvestment Ratio of 0.19x as of December 2025, meaning it reinvests 0% of its operating cash flow ($506.00K) in capital expenditures ($97.00K). Check NPCE tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.19x

Capex / Operating Cash Flow

Operating Cash Flow

$506.00K

USD

Capital Expenditures

$97.00K

USD

Data as of

Dec 2025

Most recent filing

Annual Capital Reinvestment Ratio for Neuropace Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Neuropace Inc from None to None. See Neuropace Inc (NPCE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow